Introduction
validation group. We recruited a total of 768 cases from 2 different hospitals in Harbin, China. The initial training set included 265 patients with thyroid cancer and 243 patients with benign thyroid diseases who were admitted to the Third Affiliated Hospital, Harbin Medical University between January 2014 and June 2014. The validation set included 130 patients with thyroid cancer and 130 patients with benign thyroid diseases who were admitted to the Second Affiliated Hospital, Harbin Medical University between January 2014 and June 2014. The patients with benign thyroid diseases were matched for age, gender, body mass index (BMI), and smoking status. Inclusion criteria were as follows: (1) undergone complete surgical resection and diagnosis of thyroid cancer was confirmed by histology; (2) without distant metastasis at diagnosis; (3) untreated prior to blood collection. Exclusion criteria included: hematological disorders, autoimmune diseases, systemic inflammatory diseases, coronary artery disease, hypertension, diabetes mellitus, renal disease, hepatic disorder and other cancer, and medical treatment with anticoagulant, statins, and acetylic salicylic acid.
The study protocol was approved by the Ethics Committee of the Second and Third Affiliated Hospital of Harbin Medical University, Harbin, China. Written informed consents were obtained from all participants.
Clinical examination and biochemical measurements All the subjects underwent physical examination. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m 2 ). Clinical data included smoking status, medical history and medication use. The whole blood samples were drawn after an 8-h overnight fasting and all samples were processed within 30 min after blood collection. White blood cell (WBC), hemoglobin, and platelet indices were determined with an autoanalyzer (Sysmex XE-2100, Kobe, Japan). The inter-and intra-assays coefficients of variation (CVs) were below 5%.
Statistical analyses All data was expressed as means ± SD or median (interquartile range) or percentage. When the characteristics between two groups were compared, continuous variables were compared with the Student t test. When the characteristics among three groups were compared, continuous variables were compared with the one-way ANOVA. Receiver-operating characteristic curves were used to define sensitivity and specificity, and the differences in the area under the curve (AUC) were detected by using MedCalc version 13.0. A two-tailed significance threshold of 0.05 was used for all statistical tests, performed using SPSS version 22.0 (SPSS Inc., Chicago, IL, USA).
Results
The baseline characteristics of the patients are shown in Table 1 . In the development set, the mean age of the patient with benign thyroid disease and thyroid cancer was 46.3 (9.8) years and 50.7 (5.1) years, respectively. Most of the patients were female and had multiple nodules. The common pathological type of benign thyroid disease and thyroid cancer are nodular goiter and papillary carcinoma, respectively. Most of the patients with thyroid cancer had low incidence of lymph node metastasis (n = 33; 12.5%) and were diagnosed as T1 (n=223; 84.2%) and stage I (n = 224; 84.5%). In the validation set, similar results were found.
Albumin, MPV and PDW levels in benign thyroid disease and thyroid cancer are shown in Table 2 . The levels of albumin and MPV are significantly reduced and PDW are significantly increased among the patients with thyroid cancer compared to the benign cases in both the development and validation sets (p < 0.001).
We evaluated the levels of albumin, MPV and PDW Table 4 , the sensitivity, specificity, positive predictive value, negative predictive value, and area under curve (AUC) values are presented for MPV, PDW, albumin, the combination of albumin and MPV, the combination of albumin and PDW. To determine the predictive accuracy of each of the significant independent multivariate biomarkers based on the optimal cutoff values, we used ROC analysis to assess the AUC for single biomarkers and the combination of three (Table 4) . When used to analyze benign thyroid masses versus thyroid cancer, PDW had the highest sensitivity (92.1%), but at the cost of an unsatisfactory low specificity (45.7% ). Albumin had the highest specificity (88.9%) with an low sensitivity (50.9% ). The specificity of PDW and the sensitivity of albumin increased when the combination of PDW and albumin were applied. Single biomarkers had AUC values ranging from 0.692 for MPV to 0.741 for albumin; the combination of MPV and albumin or the combination of PDW and albumin increased the AUC to 0.768 (p = 0.0005) and 0.824 (p < 0.0001), respectively. In addition, the combination of PDW and albumin exhibited a significantly larger AUC of 0.824 (0.788-0.856) in comparison with the combination of MPV and albumin (p = 0.0014) (see Figure 1 and Figure 2 ). levels in various benign thyroid disease and thyroid cancer of various pathological types (Table 3 ). In the development set, we found that albumin, MPV and PDW levels are not markedly different in different types of benign thyroid disease. Although MPV is not different in 
Discussion
Thyroid cancer is the most rapidly increasing cancer among women and the second among men. However, tumor marker evaluation in early screening is not satisfactory. In this study, we showed that the combined use of PDW and albumin can be accurately distinguished cervical cancer from benign thyroid masses.
Accumulating experimental and clinical evidences support the hypothesis that platelet activation during cancer promotes disease progression. We found that reduced MPV and increased PDW in patients with thyroid cancer. Although the mechanism is unclear, bone marrow cells (including megakaryocytes) dys-regulation may contribute to changed MPV and PDW. Platelet volume is determined both during megakaryopoiesis and during thrombopoiesis. Megakaryocytic maturation, platelet production and platelet size could be modulated by cytokines, such as interleukin-6 (IL-6), granulocytes colony stimulating factor (G-CSF) and macrophage colony stimulating factor (M-CSF) (Kaushansky, 1998) . Furthermore, megakaryopoiesis and subsequent thrombopoiesis in cancer may be stimulated by the cytokines G-CSF and M-CSF, which could be secreted by tumor cells (Kowanetz et al., 2010) . MPV and PDW were early indicators of activated platelets. Reduced MPV was regarded as an enhanced consumption of large platelets in inflammatory states (Kapsoritakis et al., 2001 ). In addition, MPV has been shown to be positively associated with levels of thrombopoietin and interleukin-6, cytokines that regulate megakaryocyte ploidy (Martin et al., 1983; Brown et al., 1997) . Platelet distribution width is a measure of platelet heterogeneity. The heterogeneity in platelet volume is caused by heterogeneous demarcation of megakarocytes (Paulus, 1981) . Recent new evidences suggest that thyroid stimulating hormone is an independent predictor for the diagnosis of thyroid malignancy in patients with nodular thyroid disease (Boelaert, 2009; Dorange et al., 2011; He et al., 2016) . However, a cross-sectional study did not find any association between PDW and thyroid function (Ren et al., 2016) . Further studies are awaited to clarify the true relationship between PDW and thyroid cancer.
Patients' nutritional status is closely linked to cancer mortality, with one third of deaths being caused by malnutrition (Garcia-Luna et al., 2006) . Serum albumin reflects the nutritional status of cancer patients and is a negative prognostic factor for survival in non-small cell lung cancer, breast cancer, ovarian cancer, advanced gastric cancer, head and neck cancer, colon and rectal carcinomas, hepatocellular carcinoma (Tateishi et al., 2005; Boonpipattanapong and Chewatanakornkul, 2006; Ataseven et al., 2015; Tanriverdi et al., 2015; Yamashita et al., 2015; Danan et al., 2016) . In addition, albumin is a negative acute-phase protein affected by inflammatory states (Yeun and Kaysen, 1998; Al-Shaiba et al., 2004) . Thus, albumin has been often investigated in the prognostic index models in patients with cancer. C-reactive protein/albumin ratio is a poor prognostic indicator in small-cell lung cancer, gastric cancer, colorectal cancer, esophageal cancer, and pancreatic cancer Zhou et al., 2015; Ishizuka et al., 2016; Matsuda et al., 2016; Wu et al., 2016) . Hypoalbuminemia is an objective parameter of malnutrition and PDW is an index of activated platelet. Furthermore, measurement of serum albumin and PDW is simple and cost-effective in clinical practice.
For the diagnosis of thyroid cancer, few tumor markers are highly sensitive or specific. Thyroglobulin has low specificity and sensitivity. Our study demonstrated that the AUC values for discriminating thyroid cancer patients from benign thyroid masses using this three biomarkers were 0.875 and 0.938, respectively, significantly higher than those of any single index. In addition, MPV, PDW, and albumin levels are routinely recorded in the clinical setting and can be easily estimated prior to treatment. Thus, a combination of three serum markers is a more comprehensive indicator for thyroid cancer detection than single biomarker.
In conclusion, the study showed that the combined 
